<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">arthyper</journal-id><journal-title-group><journal-title xml:lang="ru">Артериальная гипертензия</journal-title><trans-title-group xml:lang="en"><trans-title>"Arterial’naya Gipertenziya" ("Arterial Hypertension")</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1607-419X</issn><issn pub-type="epub">2411-8524</issn><publisher><publisher-name>Antihypertensive League</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18705/1607-419X-2022-28-6-650-658</article-id><article-id custom-type="elpub" pub-id-type="custom">arthyper-2242</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Гипотензивные эффекты комбинаций лекарственных препаратов у пациентов пожилого и старческого возраста с контролируемой артериальной гипертензией</article-title><trans-title-group xml:lang="en"><trans-title>Hypotensive effects of drug combinations in elderly and old patients with controlled arterial hypertension</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7768-5632</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Коваленко</surname><given-names>Ф. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kovalenko</surname><given-names>F. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Коваленко Федор Андреевич — кандидат медицинских наук, ассистент кафедры терапии № 2 факультета повышения квалификации и профессиональной переподготовки специалистов </p><p>ул. им. Митрофана Седина, д. 4, Краснодар, 350063</p></bio><bio xml:lang="en"><p>Fedor A. Kovalenko, Candidate of Medical Sciences, Assistant Professor of Therapy No. 2, Faculty of Advanced Vocational Training and Retraining</p><p>4 Mitrofana Sedina str., Krasnodar, 350063</p></bio><email xlink:type="simple">fedor-kovalenko1990@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1510-9204</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Канорский</surname><given-names>С. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Kanorskii</surname><given-names>S. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Канорский Сергей Григорьевич — доктор медицинских наук, профессор, заведующий кафедрой терапии № 2 факультета повышения квалификации и профессиональной переподготовки специалистов</p><p>Краснодар</p></bio><bio xml:lang="en"><p>Sergey G. Kanorskii, Doctor of Medical Sciences, Professor, Head of Chair of Therapy No. 2, Faculty of Advanced Vocational Training and Retraining</p><p>Krasnodar,</p></bio><email xlink:type="simple">kanorskysg@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Кубанский государственный медицинский  университет» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kuban State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>05</day><month>09</month><year>2022</year></pub-date><volume>28</volume><issue>6</issue><fpage>650</fpage><lpage>658</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Коваленко Ф.А., Канорский С.Г., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Коваленко Ф.А., Канорский С.Г.</copyright-holder><copyright-holder xml:lang="en">Kovalenko F.A., Kanorskii S.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://htn.almazovcentre.ru/jour/article/view/2242">https://htn.almazovcentre.ru/jour/article/view/2242</self-uri><abstract><p>Цель исследования — оценить встречаемость артериальной гипотензии, ортостатической гипотензии (ОГ), пониженного артериального давления (АД) и их клинических проявлений у пациентов пожилого и старческого возраста с контролируемым течением артериальной гипертензии (АГ), принимающих комбинации препаратов на основе ингибитора ангиотензинпревращающего фермента (ИАПФ).</p><sec><title>Материалы и методы</title><p>Материалы и методы. В исследование был включен 171 житель Краснодарского края мужского и женского пола с АГ, контролируемой медикаментозно (АД менее 140/90 мм рт. ст. на фоне предшествовавшей антигипертензивной терапии, содержащей ИАПФ периндоприл), и заболеваниями атеросклеротического генеза. Всем больным проводили анкетирование, тестирование на контроль равновесия, определяли риск падений по шкале Морсе, гипотензию в ортостазе, измеряли офисное АД, выполняли суточное мониторирование АД с определением индексов времени гипотензии и времени пониженного АД.</p></sec><sec><title>Результаты</title><p>Результаты. Наиболее часто пациенты принимали комбинации ИАПФ с блокаторами кальциевых каналов (БКК) (28,1 % случаев), бета-адреноблокаторами (ББ) (27,1 %) или диуретиками (29,1 %). При оценке риска падений по шкале Морсе отмечался значимо более низкий его уровень у пациентов, принимавших комбинацию периндоприла с БКК в сравнении с получавшими периндоприл с ББ (15 против 25 баллов соответственно, p = 0,042). Больные, принимавшие периндоприл и БКК, теряли равновесие в положении «ноги вместе» в 19,3 % и в «тандемном» или «полутандемном» положении стоп в 29,8 % случаев, что было сопоставимо с группой принимавших периндоприл и диуретик (22,0 % и 33,9 % соответственно) и значимо ниже, чем в группе с терапией периндоприлом и ББ (34,5 % и 50,9 % соответственно, p = 0,043). Индексы времени пониженного систолического АД и диастолического АД при терапии периндоприлом и БКК были значимо ниже соответствующего показателя в группах пациентов, получавших периндоприл и ББ (22% и 17% против 27% и 21% соответственно, p1 = 0,020, p2 = 0,047), а индекс времени пониженного систолического АД для комбинации периндоприла и диуретика — ниже, чем для комбинации периндоприла и ББ (23% против 27% соответственно, p = 0,037). ла и диуретика — ниже, чем для комбинации периндоприла и ББ (23 % против 27 % соответственно, p = 0,037).</p></sec><sec><title>Заключение</title><p>Заключение. Полученные данные о частоте встречаемости артериальной гипотензии, ОГ и пониженного АД у пациентов пожилого и старческого возраста свидетельствуют о целесообразности дальнейшего изучения рисков медикаментозной гипотонии с целью большей персонификации лечения АГ.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To assess the frequency of arterial hypotension, orthostatic hypotension, low blood pressure (BP) and their clinical manifestations in the group of elderly and senile patients with a controlled course of arterial hypertension (AH), taking combinations of drugs based on an angiotensin-converting enzyme inhibitor (ACE inhibitor).</p></sec><sec><title>Materials and methods</title><p>Materials and methods. The study included 171 male and female residents of Krasnodar Territory with drug-controlled AH (blood pressure - BP less than 140/90 mm Hg in the background of previous antihypertensive therapy containing an ACE inhibitor perindopril), and with diseases of atherosclerotic genesis. All patients were questioned, tested for balance control, assessed for the risk of falls according to the Morse scale, hypotension in orthostasis was determined, measured office BP, carried out daily monitoring of BP with the determination of the time indices of hypotension and low BP.</p></sec><sec><title>Results</title><p>Results. Most often patients took a combination of ACE inhibitors with calcium channel blockers (CCB) (28.1% of cases), beta-blockers (BB) (27.1%) or diuretics (29.1%). Assessing the risk of falls on the Morse scale, there was a significantly lower level in patients who took the combination of perindopril with CCB compared with those who received perindopril with BB (15 versus 25 points respectively, p=0.039). Patients receiving perindopril and CCB lost balance in the “legs together” position in 19.3% and in the “tandem” or “semi-tandem” position of the feet in 29.8% of cases, that could be compared to the group taking perindopril and a diuretic (22% and 33.9%, respectively) and significantly lower than in the groups with perindopril and BB therapy (34.5% and 50.9%, respectively, p1=0.037, p2=0.043). The time index of low systolic and diastolic BP during therapy with perindopril and CCB was significantly lower than the corresponding indicator in the groups of patients treated with perindopril and BB (22% and 17% versus 27% and 21%, respectively, p1=0,009, p2=0,024), and the time index of low systolic BP for the combination of perindopril and diuretic is lower than for the combination of perindopril and BB (23% versus 27%, respectively, p=0.023).</p></sec><sec><title>Conclusion</title><p>Conclusion. The data obtained on the frequency of arterial hypotension, orthostatic hypotension and low BP in the group of elderly and senile patients indicate the advisability of further studying the risks of drug hypotension in order to better personalize the treatment of AH.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>артериальная гипертензия</kwd><kwd>артериальная гипотензия</kwd><kwd>ортостатическая гипотензия</kwd><kwd>суточное мониторирование</kwd><kwd>антигипертензивная терапия</kwd><kwd>персонификация терапии</kwd></kwd-group><kwd-group xml:lang="en"><kwd>arterial hypertension</kwd><kwd>arterial hypotension</kwd><kwd>orthostatic hypotension</kwd><kwd>24-hour monitoring</kwd><kwd>antihypertensive therapy</kwd><kwd>personification of therapy</kwd></kwd-group><funding-group><funding-statement xml:lang="en">no</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Бойцов С.А, Деев А.Д., Шальнова С.А. Смертность и факторы риска неинфекционных заболеваний в России: особенности, динамика, прогноз. Терапевтический архив. 2017;89(1):5-13.. doi: 10.17116/terarkh20178915-13.</mixed-citation><mixed-citation xml:lang="en">Boytsov SA, Deev AD, Shalnova SA. Mortality and risk factors for non-communicable diseases in Russia: Specific features, trends and prognosis. Terapevticheskii Arkhiv (Ter. Arkh.) 2017;89(1):5-13. doi: 10.17116/terarkh20178915-13. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953-2041. doi: 10.1097/HJH.0000000000001940.</mixed-citation><mixed-citation xml:lang="en">Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953-2041. doi: 10.1097/HJH.0000000000001940.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">SPRINT Research Group, Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV et al. The SPRINT Research Group. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015;373(22):2103-2116. doi: 10.1056/NEJMoa1511939.</mixed-citation><mixed-citation xml:lang="en">SPRINT Research Group, Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV et al. The SPRINT Research Group. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015;373(22):2103-2116. doi: 10.1056/NEJMoa1511939.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Артериальная гипертензия у взрослых. Клинические рекомендации 2020. Российский кардиологический журнал. 2020;25(3):3786. [Arterial hypertension in adults. Clinical guidelines 2020. Russian Journal of Cardiology. 2020;25(3):3786. doi:10.15829/1560-4071-2020-3-3786. In Russian].</mixed-citation><mixed-citation xml:lang="en">Артериальная гипертензия у взрослых. Клинические рекомендации 2020. Российский кардиологический журнал. 2020;25(3):3786. [Arterial hypertension in adults. Clinical guidelines 2020. Russian Journal of Cardiology. 2020;25(3):3786. doi:10.15829/1560-4071-2020-3-3786. In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Оганов Р.Г., Симаненков В.И., Бакулин И.Г., Бакулина Н.В., Барбараш О.Л., Бойцов С.А., и др. Коморбидная патология в клинической практике. Клинические рекомендации. Кардиоваскулярная терапия и профилактика. 2019;18(1):5-66. doi: 10.15829/1728-8800-2019-1-5-66.</mixed-citation><mixed-citation xml:lang="en">Oganov RG, Simanenkov VI, Bakulin IG, Bakulina NV, Barbarash OL, Boytsov SA et al. Comorbidities in clinical practice. Algorithms for diagnostics and treatment. Cardiovascular Therapy and Prevention. 2019;18(1):5-66. doi: 10.15829/1728-8800-2019-1-5-66. In Russian]</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21(2):69-72. doi: 10.1007/s10286-011-0119-5.</mixed-citation><mixed-citation xml:lang="en">Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21(2):69-72. doi: 10.1007/s10286-011-0119-5.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Shen S, He T, Chu J, He J, Chen X. Uncontrolled hypertension and orthostatic hypotension in relation to standing balance in elderly hypertensive patients. Clin Interv Aging. 2015;10:897-906. doi: 10.2147/CIA.S81283.</mixed-citation><mixed-citation xml:lang="en">Shen S, He T, Chu J, He J, Chen X. Uncontrolled hypertension and orthostatic hypotension in relation to standing balance in elderly hypertensive patients. Clin Interv Aging. 2015;10:897-906. doi: 10.2147/CIA.S81283.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Juraschek SP, Appel LJ, Miller ER 3rd, Mukamal KJ, Lipsitz LA. Hypertension Treatment Effects on Orthostatic Hypotension and Its Relationship With Cardiovascular Disease. Hypertension. 2018;72(4):986-993. doi: 10.1161/HYPERTENSIONAHA.118.11337.</mixed-citation><mixed-citation xml:lang="en">Juraschek SP, Appel LJ, Miller ER 3rd, Mukamal KJ, Lipsitz LA. Hypertension Treatment Effects on Orthostatic Hypotension and Its Relationship With Cardiovascular Disease. Hypertension. 2018;72(4):986-993. doi: 10.1161/HYPERTENSIONAHA.118.11337.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Остроумова О.Д., Ших Е.В., Реброва Е.В., Рязанова А.Ю. Ортостатическая гипотензия как модифицируемый фактор риска развития когнитивных нарушений: обзор литературы. Неврология, нейропсихиатрия, психосоматика. 2019;11(1):109-116. DOI: 10.14412/2074-2711-2019-1-109-116.</mixed-citation><mixed-citation xml:lang="en">Остроумова О.Д., Ших Е.В., Реброва Е.В., Рязанова А.Ю. Ортостатическая гипотензия как модифицируемый фактор риска развития когнитивных нарушений: обзор литературы. Неврология, нейропсихиатрия, психосоматика. 2019;11(1):109-116. [Ostroumova OD, Shikh EV, Rebrova EV, Ryazanova AYu. Orthostatic hypotension as a modifiable risk factor for cognitive impairment: a literature review. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(1):109-116. DOI: 10.14412/2074-2711-2019-1-109-116. In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Falcão RMM, Costa KNFM, Fernandes MDGM, Pontes MLF, Vasconcelos JMB, Oliveira JDS. Risk of falls in hospitalized elderly people. Rev Gaucha Enferm. 2019;40(spe):e20180266. doi: 10.1590/1983-1447.2019.20180266.</mixed-citation><mixed-citation xml:lang="en">Falcão RMM, Costa KNFM, Fernandes MDGM, Pontes MLF, Vasconcelos JMB, Oliveira JDS. Risk of falls in hospitalized elderly people. Rev Gaucha Enferm. 2019;40(spe):e20180266. doi: 10.1590/1983-1447.2019.20180266.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Nasrallah IM, Gaussoin SA, Pomponio R, Dolui S, Erus G, Wright CB et al. SPRINT Research Group. Association of intensive vs standard blood pressure control with magnetic resonance imaging biomarkers of Alzheimer disease: secondary analysis of the SPRINT MIND randomized trial. JAMA Neurology. 2021;78(5):568-577. doi: 10.1001/jamaneurol.2021.0178.</mixed-citation><mixed-citation xml:lang="en">Nasrallah IM, Gaussoin SA, Pomponio R, Dolui S, Erus G, Wright CB et al. SPRINT Research Group. Association of intensive vs standard blood pressure control with magnetic resonance imaging biomarkers of Alzheimer disease: secondary analysis of the SPRINT MIND randomized trial. JAMA Neurology. 2021;78(5):568-577. doi: 10.1001/jamaneurol.2021.0178.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ткачева О.Н., Рунихина Н.К., Котовская Ю.В., Шарашкина Н.В., Остапенко В.С., Недогода С.В. Лечение артериальной гипертонии у пациентов 80 лет и старше и пациентов со старческой астенией. Кардиоваскулярная терапия и профилактика. 2017;16(1):8-21. doi: 10.15829/1728-8800-2017-1-8-21. In Russian.</mixed-citation><mixed-citation xml:lang="en">Tkacheva ON, Runikhina NK, Kotovskaya YuV, Sharashkina NV, Ostapenko VS, Nedogoda SV. Arterial hypertension management in patients aged older than 80 years and patients with the senile asthenia. Cardiovascular Therapy and Prevention. 2017;16(1):8-21. doi: 10.15829/1728-8800-2017-1-8-21. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49(2):M85-94. doi: 10.1093/geronj/49.2.m85.</mixed-citation><mixed-citation xml:lang="en">Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49(2):M85-94. doi: 10.1093/geronj/49.2.m85.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Benvenuto LJ, Krakoff LR. Morbidity and mortality of orthostatic hypotension: implications for management of cardiovascular disease. Am J Hypertens. 2011;24(2):135-144. doi: 10.1038/ajh.2010.146.</mixed-citation><mixed-citation xml:lang="en">Benvenuto LJ, Krakoff LR. Morbidity and mortality of orthostatic hypotension: implications for management of cardiovascular disease. Am J Hypertens. 2011;24(2):135-144. doi: 10.1038/ajh.2010.146.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Dinicolantonio JJ, Lavie CJ, O'Keefe JH. Not all angiotensin-converting enzyme inhibitors are equal: focus on ramipril and perindopril. Postgrad Med. 2013;125(4):154-168. doi: 10.3810/pgm.2013.07.2687.</mixed-citation><mixed-citation xml:lang="en">Dinicolantonio JJ, Lavie CJ, O'Keefe JH. Not all angiotensin-converting enzyme inhibitors are equal: focus on ramipril and perindopril. Postgrad Med. 2013;125(4):154-168. doi: 10.3810/pgm.2013.07.2687.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Godfraind T. Discovery and Development of Calcium Channel Blockers. Front Pharmacol. 2017;8:286. doi: 10.3389/fphar.2017.00286.</mixed-citation><mixed-citation xml:lang="en">Godfraind T. Discovery and Development of Calcium Channel Blockers. Front Pharmacol. 2017;8:286. doi: 10.3389/fphar.2017.00286.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
